Fri May 26, 2023 – 1:24 pm EDTFri May 26, 2023 – 1:40 pm EDT
(LifeSiteNews) — A recent study sponsored by the U.S. Food and Drug Administration (FDA) is showing that children of certain ages who receive the Pfizer COVID-19 vaccine experience a heightened risk of heart inflammation.
Published in the Journal of the American Medical Association (JAMA) on May 22, the study assessed records from commercial databases hosted by CVS Health, HealthCore and Optum focusing on records from the date of the FDA’s emergency use authorization of the product, December 11, 2020, to mid-2022.
The researchers’ analysis revealed incident levels for myocarditis and pericarditis, types of heart-related inflammation, to be high enough for triggering a safety signal in the age groups of 12 to 15 years and 16 to 17 years following injection with the gene-based biological.
Discovering 153 cases in this entire age group, 12 to 17, the analysts were able to obtain medical records for 37 of these children, of which they could confirm 27 (73%) to be “true cases of myocarditis or pericarditis.” Of these 27 young patients, 25 were male (92.6%) and 19 were hospitalized with a mean length of stay
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors